Table 3.
Clinicopathological characteristics | n | High expression | Low expression | P value |
---|---|---|---|---|
Sex | 0.546 | |||
Male | 25 | 13 (25.5%) | 12 (24.5%) | |
Female | 75 | 38 (74.5%) | 37 (75.5%) | |
Age | ||||
<45y | 43 | 22 (43.1%) | 21 (42.9%) | 0.569 |
≥45y | 57 | 29 (56.9%) | 28 (57.1%) | |
Multifocality | 0.549 | |||
Unifocal | 73 | 37 (72.5%) | 36 (73.5%) | |
Multifocal | 27 | 14 (27.5%) | 13 (26.5%) | |
Tumor (T) | 0.091 | |||
T1a | 67 | 30 (58.8%) | 37 (75.5%) | |
T1b | 33 | 21 (41.2%) | 12 (24.5%) | |
Lymph node (N) | 0.000 | |||
N0 | 56 | 15 (29.4%) | 41 (83.7%) | |
N1a/N1b | 44 | 36 (70.6%) | 8 (16.3%) | |
Metastasis (M) | / | |||
M0 | 100 (100%) | / | / | |
pTNM stage | 0.000 | |||
Early (I/II) | 76 | 31 (60.8%) | 45 (91.8%) | |
Advanced (III/IV) | 24 | 20 (39.2%) | 4 (8.2%) |